financetom
Business
financetom
/
Business
/
PRESS DIGEST-New York Times business news - February 19
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PRESS DIGEST-New York Times business news - February 19
Feb 18, 2025 10:37 PM

Feb 19 (Reuters) - The following are the top stories on

the New York Times business pages. Reuters has not verified

these stories and does not vouch for their accuracy.

- The PGA Tour and Saudi Arabia's sovereign wealth fund are

working on a merger deal for their golf circuits, emboldened by

U.S. President Donald Trump's eagerness to play peacemaker for a

fractured sport.

- HP is acquiring Humane, the start-up behind the Ai

Pin device, for $116 million to enhance its A.I. capabilities,

marking the end of Humane's ambitious but unsuccessful attempt

to replace smartphones.

- A California legislator has reintroduced a bill to ban the

sale of anti-aging skin care products to minors, aiming to

protect minors from potentially harmful ingredients.

- Mira Murati, former chief technology officer of OpenAI,

has founded a new AI start-up called Thinking Machines Lab,

aiming to make AI systems more understandable and customizable

through open-source technologies.

(Compiled by Bengaluru newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Rhythm Names PANTHERx Rare as Exclusive US Pharmacy Partner for Imcivree's Expanded Indication
Rhythm Names PANTHERx Rare as Exclusive US Pharmacy Partner for Imcivree's Expanded Indication
Mar 20, 2026
01:43 PM EDT, 03/20/2026 (MT Newswires) -- Rhythm Pharmaceuticals ( RYTM ) has selected PANTHERx Rare as the exclusive US pharmacy distribution partner for the expanded indication of Imcivree, or setmelanotide, to treat acquired hypothalamic obesity in patients aged 4 years and older, PANTHERx Rare said Friday. Acquired hypothalamic obesity is a rare disease with weight gain caused by an...
Janus Living Shares Rise in NYSE Debut
Janus Living Shares Rise in NYSE Debut
Mar 20, 2026
01:43 PM EDT, 03/20/2026 (MT Newswires) -- Janus Living (JAN) shares rose in their trading debut Friday on the New York Stock Exchange. The shares were up more than 16% at $23.36 in afternoon trading. The senior housing real estate investment trust priced its upsized initial public offering of 42 million shares at $20.00 apiece. After the IPO, Healthpeak Properties...
ImmunityBio Wins Macau Approval for Anktiva in Bladder Cancer
ImmunityBio Wins Macau Approval for Anktiva in Bladder Cancer
Mar 20, 2026
01:33 PM EDT, 03/20/2026 (MT Newswires) -- ImmunityBio ( IBRX ) said Friday that the Pharmaceutical Administration Bureau of the Macau Special Administrative Region, China, approved Anktiva, or nogapendekin alfa inbakicept-pmln, marking the drug's first authorization in Asia. The drug is approved for use in combination with Bacillus Calmette-Guerin to treat adults with BCG-unresponsive non-muscle invasive bladder cancer, including carcinoma...
BRIEF-Banco Macro Says It Has Entered Into Share Purchase Agreement To Acquire Banco Sáenz S.A.
BRIEF-Banco Macro Says It Has Entered Into Share Purchase Agreement To Acquire Banco Sáenz S.A.
Mar 20, 2026
March 20 (Reuters) - Banco Macro SA: * BANCO MACRO S.A. ANNOUNCES THAT IT HAS ENTERED INTO A SHARE PURCHASE AGREEMENT TO ACQUIRE BANCO SÁENZ S.A. * BANCO MACRO SA - PURCHASE PRICE EQUALS SHAREHOLDERS' EQUITY PLUS US$2 MILLION, SUBJECT TO ADJUSTMENTS ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved